Unnati Pharmax

Imitikast 100mg Tablet
Composition: Imatinib Mesylate 100mg
International Trade Name: Gleevec®

Imitikast 100 is a premium Imatinib Mesylate 100mg Tablet, a trusted biosimilar equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand name Gleevec®. Manufactured in WHO-GMP certified facilities, Imitikast Tablet is supplied by reputable pharmaceutical exporters from India to support effective global oncology treatment programs, particularly in chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).

Imatinib mesylate selectively inhibits the BCR-ABL tyrosine kinase, which drives the proliferation of Philadelphia chromosome-positive CML and other malignancies. Imitikast 100mg Tablet is primarily indicated for the treatment of newly diagnosed or relapsed/refractory Philadelphia chromosome-positive chronic myeloid leukemia, as well as adult patients with KIT (CD117)-positive unresectable and/or metastatic gastrointestinal stromal tumors.

Keywords: Imatinib mesylate 100mg tablet, Imitikast 100 tablet, Gleevec biosimilar, chronic myeloid leukemia treatment, gastrointestinal stromal tumor therapy, TKI oncology tablet, biologics exporter India, anticancer small molecule manufacturer India.

Imitikast 100 Imatinib Mesylate Tablet is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablet is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Imatikast 400mg Tablet

Composition: Imatinib Mesylate 400mg
International Trade Name: Gleevec®

Imatikast 400 mg (Imatinib Tablets) is a targeted anti-cancer medication used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It contains Imatinib Mesylate 400 mg, a tyrosine kinase inhibitor that works by blocking abnormal proteins such as BCR-ABL, which are responsible for the uncontrolled growth of cancer cells.

Imatinib is internationally recognized under the well-known brand names Gleevec® / Glivec® (by Novartis) and is widely used across the USA, Europe, and global markets. Imatikast 400 mg is a high-quality generic alternative that provides the same therapeutic benefits at a more affordable price.

This medication is commonly prescribed as a first-line treatment for CML and is also effective in managing GIST and other related conditions. It helps reduce abnormal white blood cell counts, slow tumor progression, and improve long-term survival outcomes.

Key Benefits:

Targets BCR-ABL tyrosine kinase effectively

First-line treatment for CML

Helps control tumor growth in GIST

Globally trusted therapy with proven results

Usage Instructions:

Take Imatikast 400 mg exactly as prescribed by your healthcare provider, usually with food and a full glass of water to minimize stomach irritation.

Safety Information:

Use only under medical supervision. Regular monitoring of blood counts, liver function, and kidney function is essential during treatment.

International Brand Names of Imatinib:

Gleevec®, Glivec®, Imatib, Imatinib Teva, and other branded generics available worldwide.

Imalieva 400mg Tablet
Composition: Imatinib Mesylate 400mg
International Trade Name: Gleevec®

Imalieva 400 is a high-quality Imatinib Mesylate 400mg Tablet, a trusted biosimilar equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand name Gleevec®. Manufactured in WHO-GMP certified facilities, Imalieva Tablet is supplied by reputable pharmaceutical exporters from India to support effective global oncology treatment programs, particularly in chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).

Imatinib mesylate selectively inhibits the BCR-ABL tyrosine kinase, which is constitutively active in Philadelphia chromosome-positive CML and certain other malignancies, thereby preventing cancer cell proliferation. Imalieva 400mg Tablet is primarily indicated for the treatment of newly diagnosed or relapsed/refractory Philadelphia chromosome-positive chronic myeloid leukemia, as well as adult patients with KIT (CD117)-positive unresectable and/or metastatic gastrointestinal stromal tumors.

Keywords: Imatinib mesylate 400mg tablet, Imalieva 400 tablet, Gleevec biosimilar, chronic myeloid leukemia treatment, gastrointestinal stromal tumor therapy, TKI oncology tablet, biologics exporter India, anticancer small molecule manufacturer India.

Imalieva 400 Imatinib Mesylate Tablet is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablet is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Eltromag 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Promacta®

Eltromag 25 is a high-quality Eltrombopag 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Eltromag Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty treatment programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Eltromag 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It is also used in severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where platelet count improvement is required to allow antiviral therapy.

Eltrombopag 25mg tablets, Eltromag tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Eltromag 25 Eltrombopag Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent potency, safety, and therapeutic reliability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Tromlieva 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Revolade®

Tromlieva 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Revolade®. Manufactured in WHO-GMP certified facilities, Tromlieva Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that increases platelet production by stimulating the c-Mpl receptor on bone marrow progenitor cells. Tromlieva 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, Tromlieva tablets, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Tromlieva 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality control standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Rompag 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Revolade®

Rompag 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Revolade®. Manufactured in WHO-GMP certified facilities, Rompag Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Rompag 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where increased platelet counts are required to enable antiviral therapy.

Eltrombopag 50mg tablets, Rompag tablets, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Rompag 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

ELTROMBYRA 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Promacta® / Revolade®

ELTROMBYRA 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand names Promacta® and Revolade®. Manufactured in WHO-GMP certified facilities, ELTROMBYRA Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. ELTROMBYRA 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, ELTROMBYRA tablets, Promacta generic, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

ELTROMBYRA 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality control standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Platify 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Platify 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Platify Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Platify 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag 50mg tablets, Platify tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Platify 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

ELTROMBYRA 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta® / Revolade®

ELTROMBYRA 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand names Promacta® and Revolade®. Manufactured in WHO-GMP certified facilities, ELTROMBYRA Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. ELTROMBYRA 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 50mg tablets, ELTROMBYRA tablets, Promacta generic, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

ELTROMBYRA 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Trombonamo 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Revolade®

Trombonamo 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Revolade®. Manufactured in WHO-GMP certified facilities, Trombonamo Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Trombonamo 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 50mg tablets, Trombonamo tablets, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Trombonamo 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Trombonamo 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Revolade®

Trombonamo 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Revolade®. Manufactured in WHO-GMP certified facilities, Trombonamo Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Trombonamo 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, Trombonamo tablets, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Trombonamo 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality control standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Revolade 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Revolade 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a branded formulation of the internationally recognized thrombopoietin receptor agonist also marketed under the name Promacta® in several global markets. Manufactured in WHO-GMP certified facilities, Revolade Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that promotes platelet production by stimulating the c-Mpl receptor on bone marrow progenitor cells. Revolade 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to initiate or maintain antiviral therapy.

Eltrombopag 50mg tablets, Revolade tablets, Promacta equivalent, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Revolade 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Eltromobo 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Promacta®

Eltromobo 25 mg (Eltrombopag Tablets) is an oral medication used to treat conditions associated with low platelet counts (thrombocytopenia), including chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, and severe aplastic anemia. It contains Eltrombopag 25 mg, a thrombopoietin receptor agonist that stimulates the bone marrow to increase platelet production, helping reduce the risk of bleeding.

Eltrombopag is globally recognized under well-known international brand names such as Promacta® (USA) and Revolade® (Europe/other regions, by Novartis). Eltromobo 25 mg is a high-quality generic alternative that offers the same effectiveness at a more affordable cost, making it widely accessible across international markets.

This medication is especially useful for patients who have not responded adequately to other treatments. It helps improve platelet levels, supports long-term disease management, and enhances overall quality of life.

Key Benefits:

• Increases platelet production effectively

• Reduces risk of bleeding complications

• Used in ITP, hepatitis C, and aplastic anemia

• Globally trusted molecule with proven clinical results

Usage Instructions:
Take Eltromobo 25 mg exactly as prescribed by your doctor, usually on an empty stomach. Avoid taking it with dairy products, calcium supplements, or antacids, as they may reduce its effectiveness.

Safety Information:
Use only under medical supervision. Regular monitoring of platelet counts and liver function is essential during treatment. Do not self-medicate.

International Brand Names of Eltrombopag:
Promacta®, Revolade®, Eltrombopag Teva, and other branded generics available worldwide.

Eltromobo 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Eltromobo 50 mg (Eltrombopag Tablets) is an oral medication used to treat conditions associated with low platelet counts (thrombocytopenia), including chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, and severe aplastic anemia. It contains Eltrombopag 50 mg, a thrombopoietin receptor agonist that works by stimulating the bone marrow to produce more platelets, helping reduce the risk of bleeding.

Eltrombopag is internationally recognized under the popular brand name Promacta® (Revolade® in some countries, by Novartis) and is widely prescribed across the USA, Europe, and other global markets. Eltromobo 50 mg is a high-quality generic alternative that offers the same therapeutic effectiveness at a more affordable price.

This medication plays a crucial role in increasing platelet counts, improving patient outcomes, and supporting long-term disease management in individuals with chronic or treatment-resistant conditions.

Key Benefits:

• Stimulates platelet production in the body

• Reduces risk of bleeding in low platelet conditions

• Effective in ITP, hepatitis C, and aplastic anemia

• Globally trusted molecule with proven clinical results

Usage Instructions:
Take Eltromobo 50 mg exactly as prescribed by your healthcare provider, usually on an empty stomach. Avoid taking it with dairy products, calcium supplements, or antacids, as they may affect absorption.

Safety Information:
Use under strict medical supervision. Regular monitoring of platelet counts and liver function is required during treatment. Do not self-medicate.

International Brand Names of Eltrombopag:
Promacta®, Revolade®, Eltrombopag Teva, and other branded generics available worldwide.

Trombonat 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Trombonat 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Trombonat Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Trombonat 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 50mg tablets, Trombonat tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Trombonat 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Trombonat 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Revolade®

Trombonat 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Revolade®. Manufactured in WHO-GMP certified facilities, Trombonat Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Trombonat 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, Trombonat tablets, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Trombonat 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Elromo 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Promacta®

Elromo 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Elromo Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Elromo 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, Elromo tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Elromo 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Trombonamo 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Promacta®

Trombonamo 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Trombonamo Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Trombonamo 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, Trombonamo tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Trombonamo 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Eltrog 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Revolade®

Eltrog 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Revolade®. Manufactured in WHO-GMP certified facilities, Eltrog Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Eltrog 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, Eltrog tablets, Revolade generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Eltrog 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Rebopag 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Rebopag 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Rebopag Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Rebopag 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 50mg tablets, Rebopag tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Rebopag 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Rompag 25mg Tablets
Composition: Eltrombopag Olamine Tablets 25mg
International Trade Name: Promacta®

Rompag 25 is a high-quality Eltrombopag Olamine 25mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Rompag Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Rompag 25mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 25mg tablets, Rompag tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Rompag 25 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Eltrog 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Eltrog 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Eltrog Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Eltrog 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 50mg tablets, Eltrog tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Eltrog 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Elromo 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Elromo 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Elromo Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Elromo 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 50mg tablets, Elromo tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Elromo 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Lenakast 25mg Capsule

Composition: Lenalidomide 25mg
International Trade Name: Revlimid®

Lenakast 25 mg (Lenalidomide Capsules) by Aparazer Healthcare is an oral anti-cancer and immunomodulatory medication used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain lymphomas. It contains Lenalidomide 25 mg, which works by boosting the immune system, inhibiting cancer cell growth, and preventing the formation of new blood vessels that support tumor development.

Lenalidomide is globally recognized under the well-known international brand name Revlimid® (by Bristol-Myers Squibb) and is widely prescribed across the USA, Europe, and other international markets. Lenakast 25 mg is a high-quality generic alternative that delivers the same therapeutic effectiveness at a more affordable cost.

This medication is commonly used as part of combination therapy or maintenance treatment, helping to slow disease progression, improve treatment response, and enhance overall survival outcomes in patients with hematological cancers.

Key Benefits:

• Enhances immune system response against cancer cells

• Inhibits tumor growth and angiogenesis

• Effective in multiple myeloma and MDS treatment

• Globally trusted molecule with proven clinical results

Usage Instructions:
Take Lenakast 25 mg exactly as prescribed by your healthcare provider, usually once daily. Swallow the capsule whole with water; do not crush, chew, or open it.

Safety Information:
Use under strict medical supervision. Regular monitoring of blood counts is essential. This medicine can cause serious birth defects—strict pregnancy prevention measures must be followed during treatment.

International Brand Names of Lenalidomide:
Revlimid®, Lenalid, Lenangio, and other branded generics available worldwide.

Lenakast 10mg Capsule

Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Lenakast-10 (Lenalidomide 10 mg Capsules) is an oral anti-cancer and immunomodulatory medication used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain lymphomas. It contains Lenalidomide 10 mg, which works by enhancing the immune system, inhibiting cancer cell growth, and preventing the formation of new blood vessels that support tumor development.

Lenalidomide is globally recognized under the well-known international brand name Revlimid® (by Bristol-Myers Squibb) and is widely prescribed across the USA, Europe, and other global markets. Lenakast-10 is a high-quality generic alternative that offers the same therapeutic benefits at a more affordable cost.

This medication plays a key role in improving treatment outcomes, slowing disease progression, and increasing survival rates in patients with hematological cancers. It is often used in combination with other therapies depending on the condition.

Key Benefits:

• Boosts immune response against cancer cells

• Inhibits tumor growth and blood vessel formation

• Effective in multiple myeloma and MDS

• Globally trusted molecule with proven results

Usage Instructions:
Take Lenakast-10 exactly as prescribed by your healthcare provider, usually once daily. Swallow the capsule whole with water; do not crush or open it.

Safety Information:
Use under strict medical supervision. Regular monitoring of blood counts is essential during treatment. This medicine may cause birth defects—strict precautions are required during use.

International Brand Names of Lenalidomide:
Revlimid®, Lenalid, Lenangio, and other branded generics available worldwide.

Lenangio 25mg Capsule
Composition: Lenalidomide 25mg
International Trade Name: Revlimid®

Lenangio 25 is a high-quality Lenalidomide 25mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenangio Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenangio 25mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 25mg capsule, Lenangio 25 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenangio 25 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenanamo 25mg Capsule
Composition: Lenalidomide 25mg
International Trade Name: Revlimid®

Lenanamo 25 is a high-quality Lenalidomide 25mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenanamo Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenanamo 25mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 25mg capsule, Lenanamo 25 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenanamo 25 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenalid 5mg Capsule
Composition: Lenalidomide 5mg
International Trade Name: Revlimid®

Lenalid 5 is a high-quality Lenalidomide 5mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenalid Capsule is supplied by reputable pharmaceutical exporters from India to support global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenalid 5mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 5mg capsule, Lenalid 5 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenalid 5 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenalid 10mg Capsule
Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Lenalid 10 is a high-quality Lenalidomide 10mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenalid Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenalid 10mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 10mg capsule, Lenalid 10 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenalid 10 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenanamo 10mg Capsule
Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Lenanamo 10 is a high-quality Lenalidomide 10mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenanamo Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenanamo 10mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 10mg capsule, Lenanamo 10 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenanamo 10 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenangio 10mg Capsule
Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Lenangio 10 is a high-quality Lenalidomide 10mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenangio Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenangio 10mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 10mg capsule, Lenangio 10 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenangio 10 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenalid 25mg Capsule
Composition: Lenalidomide 25mg
International Trade Name: Revlimid®

Lenalid 25 is a high-quality Lenalidomide 25mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenalid Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenalid 25mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 25mg capsule, Lenalid 25 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenalid 25 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenangio 10mg Capsule
Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Lenangio 10 is a high-quality Lenalidomide 10mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenangio Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenangio 10mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 10mg capsule, Lenangio 10 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenangio 10 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Velimide 10mg Capsule
Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Velimide 10 is a high-quality Lenalidomide 10mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Velimide Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Velimide 10mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 10mg capsule, Velimide 10 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Velimide 10 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenalid 15mg Capsule
Composition: Lenalidomide 15mg
International Trade Name: Revlimid®

Lenalid 15 is a high-quality Lenalidomide 15mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenalid Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenalid 15mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 15mg capsule, Lenalid 15 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenalid 15 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenated 10mg Capsule
Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Lenated 10 is a high-quality Lenalidomide 10mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenated Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenated 10mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 10mg capsule, Lenated 10 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenated 10 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Lenalas 10mg Capsule
Composition: Lenalidomide 10mg
International Trade Name: Revlimid®

Lenalas 10 is a high-quality Lenalidomide 10mg Capsule, a trusted biosimilar equivalent of the internationally recognized immunomodulatory agent marketed under the brand name Revlimid®. Manufactured in WHO-GMP certified facilities, Lenalas Capsule is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in hematologic malignancies.

Lenalidomide modulates the immune system, inhibits angiogenesis, and induces apoptosis in malignant cells, making it highly effective in treating certain cancers. Lenalas 10mg Capsule is primarily indicated for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and mantle cell lymphoma, especially in patients who have received prior therapy.

Keywords: Lenalidomide 10mg capsule, Lenalas 10 capsule, Revlimid biosimilar, immunomodulatory agent, multiple myeloma therapy, MDS treatment, mantle cell lymphoma therapy, oncology capsule, biologics exporter India, anticancer small molecule manufacturer India.

Lenalas 10 Lenalidomide Capsule is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsule is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Trombonamo 50mg Tablets
Composition: Eltrombopag Olamine Tablets 50mg
International Trade Name: Promacta®

Trombonamo 50 is a high-quality Eltrombopag Olamine 50mg Tablet, a generic equivalent of the internationally recognized thrombopoietin receptor agonist marketed under the brand name Promacta®. Manufactured in WHO-GMP certified facilities, Trombonamo Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global hematology and specialty care programs.

Eltrombopag is an oral thrombopoietin (TPO) receptor agonist that stimulates platelet production by activating the c-Mpl receptor on bone marrow progenitor cells. Trombonamo 50mg Tablets are primarily indicated for the treatment of chronic immune thrombocytopenia (ITP) in patients with an inadequate response to corticosteroids, immunoglobulins, or splenectomy. It is also indicated for severe aplastic anemia and thrombocytopenia associated with chronic hepatitis C, where improvement in platelet counts is required to enable antiviral therapy.

Eltrombopag Olamine 50mg tablets, Trombonamo tablets, Promacta generic, Eltrombopag price, immune thrombocytopenia treatment, platelet booster medicine, hematology drug exporter India, and thrombopoietin receptor agonist manufacturer India.

Trombonamo 50 Eltrombopag Olamine Tablets are manufactured under stringent GMP and quality assurance standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology clinics, tertiary care hospitals, government health programs, and international pharmaceutical distributors.

Dasatib 50mg Tablets
Composition: Dasatinib Tablets 50mg
International Trade Name: Sprycel®

Dasatib 50 is a high-quality Dasatinib 50mg Tablet, a generic equivalent of the internationally recognized tyrosine kinase inhibitor (TKI) marketed under the brand name Sprycel®. Manufactured in WHO-GMP certified facilities, Dasatib Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL).

Dasatinib is a second-generation BCR-ABL tyrosine kinase inhibitor that blocks abnormal signaling pathways responsible for uncontrolled proliferation of leukemic cells. Dasatib 50mg Tablets are primarily indicated for the treatment of chronic, accelerated, or blast phase Ph+ CML in patients who are newly diagnosed or resistant or intolerant to prior therapy, including imatinib. It is also used for Ph+ ALL in adults.

Dasatinib 50mg tablets, Dasatib tablets, Sprycel generic, Dasatinib price, chronic myeloid leukemia treatment, tyrosine kinase inhibitor, targeted oncology therapy, anticancer drug exporter India, and leukemia treatment manufacturer India.

Dasatib 50 Dasatinib Tablets are manufactured under stringent GMP and oncology quality standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology-oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Dasatib 100mg Tablets
Composition: Dasatinib Tablets 100mg
International Trade Name: Sprycel®

Dasatib 100 is a high-quality Dasatinib 100mg Tablet, a generic equivalent of the internationally recognized tyrosine kinase inhibitor (TKI) marketed under the brand name Sprycel®. Manufactured in WHO-GMP certified facilities, Dasatib Tablets are supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL).

Dasatinib is a second-generation BCR-ABL tyrosine kinase inhibitor that blocks abnormal signaling pathways responsible for uncontrolled proliferation of leukemic cells. Dasatib 100mg Tablets are primarily indicated for the treatment of chronic, accelerated, or blast phase Ph+ CML in patients who are newly diagnosed or resistant or intolerant to prior therapy, including imatinib. It is also used for Ph+ ALL in adults.

Dasatinib 100mg tablets, Dasatib tablets, Sprycel generic, Dasatinib price, chronic myeloid leukemia treatment, tyrosine kinase inhibitor, targeted oncology therapy, anticancer drug exporter India, and leukemia treatment manufacturer India.

Dasatib 100 Dasatinib Tablets are manufactured under stringent GMP and oncology quality standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making them suitable for hematology-oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.